BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Crystalgenomics Inc.

Headquarters: Seongnam, South Korea
Year Founded: 2000
Status: Public
Industry Sector: HealthTechnology
CEO: Joong-Myung Cho, PhD
Number Of Employees: N/A
Enterprise Value: N/A
PE Ratio: -3.61
Exchange/Ticker 1: KOSDAQ:083790
Exchange/Ticker 2: N/A
Latest Market Cap: $124,173,760

BioCentury | May 26, 2021
Product Development

Korea Spotlight: Shaking off BI setback, Bridge expands scope of BD, advances in-house therapies 

James Lee-led biotech has honed its focus and begun seeking deals as far off as Europe
BioCentury | Nov 21, 2016
Strategy

LG’s biotech legacy

How LG's shifting focus helped spawn a new biotech industry in South Korea
BioCentury | Jun 13, 2016
Company News

CrystalGenomics, Aptose Biosciences deal

BioCentury | Mar 21, 2016
Product Development

Korea rising

How the Korean biopharma landscape is evolving
BioCentury | Feb 16, 2015
Clinical News

Acelex polmacoxib regulatory update

BioCentury | Feb 16, 2015
Company News

CrystalGenomics, Daewoong Pharmaceutical deal

BioCentury | Sep 15, 2014
Clinical News

CrystalGenomics preclinical data

BioCentury | Jun 30, 2014
Financial News

CrystalGenomics financial update

BioCentury | Jun 30, 2014
Finance

Highlights of weekly biotech stock moves

Regulatory, clinical and other milestones
Items per page:
1 - 10 of 35